Blog

Amanda Lund: IFN as a metabolic switch to prune tumor-associated lymphangiogenesis

Amanda Lund and Triantafyllia Karakousi

Dec 9, 2024, 15:08

Amanda Lund: IFN as a metabolic switch to prune tumor-associated lymphangiogenesis

“Excited to share our latest by Triantafyllia Karakousi where we find that IFNg acts as a metabolic switch to prune tumor-associated lymphangiogenesis and unlink immune surveillance and metastasis.”

IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma

Authors: Triantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, Luiz Henrique Medeiros Geraldo, Tania J. González-Robles, Gabrielle da Silva, Alec P. Breazeale, Joel Encarnacion-Rosado, Joanna Pozniak, Alec C. Kimmelman, Kelly V. Ruggles, J. Chris Marine, Navdeep S. Chandel, Amanda W. Lund

Alec C. Kimmelman Alec P. Breazeale Amanda W. Lund Gabrielle da Silva J. Chris Marine Joanna Poźniak Joel Encarnacion-Rosado Kelly V. Ruggles Luiz Henrique Medeiros Geraldo Maria Luiza Lopes de Oliveira Navdeep S. Chandel Tania J. González-Robles Triantafyllia Karakousi Vanessa Cristaldi

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage